RECRUITING

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

HIV medications can be very effective at helping patients have longer, healthier lives. However, many patients do not take their HIV medications as prescribed. This study aims to test a promising HIV medication adherence health coaching intervention delivered primarily via a smartphone application. N = 400 persons living with HIV will be enrolled across two sites (Providence, RI \& Atlanta, GA). Participants will be randomly assigned, with a 2:1 ratio, to receive a 1) health coaching session with access to a smartphone application that provides medication reminders and remote access to the health coach or a 2) health coaching session only. Participants will complete interviews at baseline, 1, 3, 6, and 12 months after baseline. Some participants will also complete interviews at 18 and 24 months after baseline. Data analysis will examine the extent to which the intervention improves ART medication adherence, as well as other factors, compared to the control condition, which approximates standard of care.

Official Title

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV

Quick Facts

Study Start:2021-10-06
Study Completion:2025-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05046392

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * at least 18 years of age
  2. * prescribed ART
  3. * diagnosed with HIV
  4. * detectable viral load (\>20 copies/mL) in past 6 months
  5. * less than 100% self-reported medication adherence
  1. * physical impairments that would prevent completion of the intervention
  2. * cognitive impairments that jeopardize informed consent and/or intervention comprehension
  3. * active psychosis
  4. * not fluent in English

Contacts and Locations

Study Contact

Susan Ramsey, PhD
CONTACT
(401) 444-7831
sramsey@lifespan.org

Study Locations (Sites)

Emory University
Atlanta, Georgia, 30322
United States
Rhode Island Hospital
Providence, Rhode Island, 02903
United States

Collaborators and Investigators

Sponsor: Rhode Island Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-06
Study Completion Date2025-10-01

Study Record Updates

Study Start Date2021-10-06
Study Completion Date2025-10-01

Terms related to this study

Keywords Provided by Researchers

  • HIV
  • Medication Adherence
  • mHealth
  • Health Coaching

Additional Relevant MeSH Terms

  • HIV
  • Medication Adherence
  • Telemedicine